Skip to main content
. 2021 Oct 20;23(1):e13355. doi: 10.1111/obr.13355
Reference Country Care‐setting Recruitment from trial Population Participants interviewed (N) Age in years, m (SD) Sex, n (%) male Ethnicity, n (%) white Facilitator Modality
Aschbrenner et al. 34 USA Three public mental health centers Yes Diagnosis of schizophrenia, schizoaffective disorder, major depression, or bipolar disorder 30 NR 15 (50%) NR One facilitator plus one operator Six semistructured focus groups each of 3–8 persons
Aschbrenner et al. 35 USA A community mental health team Trial development Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, major depression 10 46.6 (8.7) 1 (10%) 9 (90%) NR Semistructured interview; 45–60 min each
Barre et al. 46 USA Mental health center No SMI NOS 31 Range: 30–61 NR NR NR Semistructured, 1:1 interview
Bochicchio et al. 47 USA Supportive housing Yes Intervention participants self‐reported with SMI, plus intervention peer specialists and supervisors

Intervention participants: 28

Peer specialists: 4

Supervisors: 5

Intervention participants:49

(9.27)

Peer specialists: 44.72 (7.41)

Supervisors: 34.25 (10.2)

Intervention participants: 14 (50%)

Peer specialists: 2 (50%)

Supervisors: 1 (20%)

Intervention participants: 6 (21%)

Peer specialists: 1 (25%)

Supervisors: 3 (60%)

Trained research assistant A 1:1 interview; 1 h each
Carey et al. 48 UK Community mental health teams Trial development A clinical diagnosis of schizophrenia, schizoaffective disorder or FEP Unclear NR NR NR NR Participants were invited to one of four pilot cohorts to provide feedback
Every‐Palmer et al. 49 New Zealand Three medium secure units; one minimum secure; and one unlocked unit No ICD diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or psychosis NOS 51 38 (10.4) 40 (78%) 0 (0%) Researcher known to the participant Semistructured, 1:1 interview; 40 min each
Gandhi et al. 50 South India Tertiary mental health institute No ICD‐10 diagnosis of schizophrenia spectrum disorders 5 + 13 caregivers 43.2 (NR) NR NR Researcher NOS Semistructured interview; 40–60 min each
Gossage‐Worral et al. 51 UK Ten English NHS mental health trusts in urban and rural locations Trial process evaluation A clinical diagnosis of schizophrenia, schizoaffective disorder or FEP (defined as <3 years since presentation to mental health services) Intervention participants: 24 Range: 18–55 12 (50%) 20 (83.3) NR Semistructured telephone interview; median duration: 18.87; range: 13.06 to 30.33 min
Jimenez et al. 52 USA NR Yes DSM‐IV diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depression 20 40.25 (10.4) 11 (55%) 0 (0%)—all participants Latino NR Semistructured, 1:1 interview; 60–90 min each
Lesley et al. 53 USA NR Yes SMI NOS 11 NR 2 (18%) NR

Nurse researcher

A 1:1 interview
Muralidharan et al. 36 USA Greater Los Angeles Veterans Affairs Medical Centre Yes Schizophrenia spectrum disorders, affective psychoses, or posttraumatic stress disorder 48 NR NR NR NR NR
Nover 37 USA A community clinic Yes SMI NOS 11 Range: 45–63 2 (18%) 11 (100%) Lead author Semistructured, 1:1 interview; 45 min each
O'Hara et al. 38 USA Supportive housing Trial development Self‐reported SMI including schizophrenia or schizoaffective disorder, bipolar disorder, major depression 8 NR for the qualitative study NR for the qualitative study NR for the qualitative study Research assistant Two focus groups and field notes
Olmos‐Ochoa et al. 39 USA NR Yes DSM‐IV diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, recurrent major depressive disorder with psychosis, or chronic posttraumatic stress disorder

Participants from MOVE! SMI: 24

Participants from WebMOVE: 24

Participants from MOVE! SMI: 53.7 (10.5)

Participants from WebMOVE: 45.4 (6.0)

Participants from MOVE! SMI: Unclear (21%)

Participants from WebMOVE: Unclear (19%)

Participants from MOVE! SMI: 12 (50%)

Participants from WebMOVE: 7 (29.2%)

Three assessors NOS A 1:1 interview; 15–30 min
Park et al. 40 Australia NR Yes Diagnosed with schizophrenia 10 Range: 30–65 2 (20%) NR Mental health professional not involved in the RCT Interview in a setting of participants' choice; 30–60 min
Pearsall et al. 41 UK A community mental health team No—perspectives of those who declined to participate in a trial Diagnosis of schizophrenia, schizoaffective or bipolar affective disorder 13 54.6 (NR) Unclear (50%) NR

Lead author

Interview at the community base or participants' home; 30–40 min
Sayer et al. 42 USA A supportive housing building and nearby neighbourhoods No SMI NOS

55.

Note: only 38 participants provided personal and demographic characteristics

52.4 (NR) 17 (44.7%) 0 (0%)—all participants were African American Team leader with experience of mental illness Five focus groups with 6–12 persons; 90 min each
Shiner et al. 43 USA NR Yes SMI NOS 8 43.0 (±15.3) 5 (62.5%) 8 (100%) Lead author Semistructured, 1:1 interview; 1 h each
Vazin et al. 44 USA Six psychiatric rehabilitation program sites Yes Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, major depression or other diagnosis 20 Range: 20–70 10 (50%) 14 (70%) Intervention staff Semistructured, 1:1 interview; 20–30 min each
Yarborough et al. 45 USA Three community mental health clinics Yes Diagnosis of schizophrenia or schizoaffective disorder, bipolar disorder, affective psychosis, or PTSD 84 48.1 (10.1) 30 (36%) 66 (79%) Master's and doctoral level research staff A 1:1 interview

Note: DSM‐IV, Diagnostic and Statistical Manual of Mental Health Disorders, 4th Edition; FEP, first episode psychosis; ICD‐10, International Statistical Classification of Diseases and Related Health Problems 10th Edition; NOS, not otherwise specified; NR, not reported; SMI, serious mental illness; 1:1, one‐to‐one.